HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
HealthEquity reported Q2 revenue of $350.7 million, up 8% year-over-year, while net income rose 10% to $65.6 million with an improved margin of 19%. Adjusted EBITDA increased 11% to $167.0 million, achieving a record margin of 48%, prompting the company to raise its fiscal 2027 revenue and earnings guidance.
Key figures
- Eps
- 0.78
- Revenue
- $350.7 million
- Guidance
- FY27 revenue $1.411B-$1.421B; net income $2.88-$2.96/sh; non-GAAP net income $4.66-$4.73/sh
- Revenue Yoy
- 8%
- Hsa assets
- $37.9 billion
- Buyback amount
- $108.1 million
- Adjusted ebitda
- $167.0 million
- Net income margin
- 19%
- Adjusted ebitda margin
- 48%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.